Finance

Beta
Lists
SRTS:NASDAQ
Sensus Healthcare Inc
US$ २.९६
-२.३१%
(-०.०७०) 1D
जुन २५, १०:१७:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTS...
Open
US$ ३.०१
High
US$ ३.०१
Low
US$ २.८१
Mkt. cap
४.९१ करोड
Avg. vol.
५८.२९ हजार
Volume
६.९३ हजार
52-wk high
US$ ५.९२
52-wk low
US$ २.६६
EPS
-US$ ०.४७
Beta
१.०९
Shares outstanding
१.६५ करोड
No. of employees
६०
Open
US$ ३.०१
High
US$ ३.०१
Low
US$ २.८१
Mkt. cap
४.९१ करोड
Avg. vol.
५८.२९ हजार
Volume
६.९३ हजार
52-wk high
US$ ५.९२
52-wk low
US$ २.६६
EPS
-US$ ०.४७
Beta
१.०९
Shares outstanding
१.६५ करोड
No. of employees
६०
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
४८ मिनेट पहिले
Nvidia (NVDA) Launches BioNeMo As Life Sciences Firms Roll Out Integrations
GlobeNewswire
GlobeNewswire
·
१९ मिनेट पहिले
Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the
citybiz
citybiz
·
१९ मिनेट पहिले
ASP Isotopes Plans Noble Africa Merger With ENDRA to Create Nasdaq-Listed Helium Company
Barron's
Barron's
·
१३ मिनेट पहिले
Wendy’s Stock Is Changing Hands More Than Micron. The Nasdaq Halts Trading.
About Sensus Healthcare Inc
CEO-
Employees६०
Founded२०१०
HeadquartersBoca Raton, फ्लोरिडा, संयुक्त राज्य अमेरिका
Sector-
Websitesensushealthcare.com
Analyst Ratings
Based on 3 analysts giving stock ratings to SRTS in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SRTS in the last 3 months.
Highest
Current US$ २.९६
US$ ६.५० (+११९.५९%)
Average
US$ ५.६७ (+९१.५५%)
Lowest
US$ ४.५० (+५२.०३%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Maintained
US$ ६.००
+१०२.७%
05/11/2026
Ben Haynor
Lake Street
Buy
Reiterated
US$ ४.५०
+५२%
05/08/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
US$ ६.५०
+११९.६%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
७३.१५ लाख
६८.८४ लाख
४९.३९ लाख
३३.९४ लाख
Cost of goods sold
४४.१२ लाख
४१.७१ लाख
३०.४२ लाख
२४.०३ लाख
Cost of revenue
४४.१२ लाख
४१.७१ लाख
३०.४२ लाख
२४.०३ लाख
Research and development expenses
१४.७१ लाख
१८.१९ लाख
१८.८२ लाख
१५.९० लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३३.७५ लाख
३४.६३ लाख
३१.६३ लाख
३७.५९ लाख
Operating expense
४८.४६ लाख
५२.८२ लाख
५०.४५ लाख
५३.४९ लाख
Total operating expenses
९२.५८ लाख
९४.५३ लाख
८०.८७ लाख
७७.५२ लाख
Operating income
-१९.४३ लाख
-२५.६९ लाख
-३१.४८ लाख
-४३.५८ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-१७.६० लाख
-२४.०९ लाख
-२९.९३ लाख
-४२.३३ लाख
EBT excluding unusual items
-१७.६० लाख
-२४.०९ लाख
-२९.९३ लाख
-४२.३३ लाख
Income tax expense
-७.२३ लाख
-१४.६६ लाख
१.७४ लाख
-१६.०७ लाख
Effective tax rate
४१.०८%
६०.८६%
-५.८१%
३७.९६%
Other operating expenses
-
-
-
-
Net income
-१०.३७ लाख
-९.४३ लाख
-३१.६७ लाख
-२६.२६ लाख
Net profit margin
-१४.१८%
-१३.७०%
-६४.१२%
-७७.३७%
Earnings per share
-०.०६
-०.०६
-०.१९
-०.१६
Interest and investment income
१.८३ लाख
१.६० लाख
१.५५ लाख
१.२५ लाख
Interest expense
-
-
-
-
Net interest expenses
१.८३ लाख
१.६० लाख
१.५५ लाख
१.२५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१८.४४ लाख
-२४.७१ लाख
-३०.४५ लाख
-४२.६२ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer